COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,626 Articles (22,913 medRxiv, 8,713 bioRxiv)

Most recent first Previous |  Page 1340: Articles 13391-13400  | Next

Characterising the persistence of RT-PCR positivity and incidence in a community survey of SARS-CoV-2
Eales, O., Walters, C. E., Wang, H., Haw, D., Ainslie, K. E. C., Atchinson, C., Page, A., Prosolek, S., Trotter, A. J., Le Viet, T., Alikhan, N.-F., Jackson, L. M., Ludden, C., The COVID-19 Genomics UK (COG-UK) Consortium, , Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P., Riley, S.
10.1101/2021.08.12.21261987 — Posted: 2021-08-13
The production of anti-PF4 antibodies in anti-phospholipid antibody-positive patients is not affected by COVID-19 vaccination
Lonati, P., Bodio, C., Scavone, M., Martini, G., Pesce, E., Bandera, A., Lombardi, A., Gerosa, M., Franceschini, F., Tincani, A., Podda, G., Abrignani, S., Grifantini, R., Cattaneo, M., Borghi, M. O., Meroni, P. L.
10.1101/2021.08.12.21261976 — Posted: 2021-08-13
Factors influencing wellbeing in young people during COVID-19.
James, M., Jones, H., Baig, A., Marchant, E., Waites, T., Todd, C., Hughes, K., Brophy, S.
10.1101/2021.08.13.21261959 — Posted: 2021-08-13
COVID-19 vaccine uptake among older people in relation to sociodemographic factors: cohort results from southern Sweden
Inghammar, M., Moghaddassi, M., Rasmussen, M., Malmqvist, U., Kahn, F., Bjork, J.
10.1101/2021.08.12.21261981 — Posted: 2021-08-13
Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland
Stringhini, S., Zaballa, M.-E., Pullen, N., Perez-Saez, J., de Mestral, C., Loizeau, A., Lamour, J., Pennacchio, F., Wisniak, A., Dumont, R., Baysson, H., Richard, V., Lorthe, E., Semaani, C., Balavoine, J.-F., Pittet, D., Vuilleumier, N., Chappuis, F., Kherad, O., Azman, A. S., Posfay-Barbe, K., Kaiser, L., Guessous, I., the Specchio-COVID19 Study Group
10.1101/2021.08.12.21261929 — Posted: 2021-08-13
Efficacy of SARS-CoV-2 vaccine in thoracic cancer patients: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses
GOUNANT, V., FERRE, V. M., SOUSSI, G., charpentier, C., FLAMENT, H., FIDOUH, N., COLLIN, G., NAMOUR, C., ASSOUN, S., BIZOT, A., BROUK, Z., VICAUT, E., TEXEIRA, L., DESCAMPS, D., ZALCMAN, G.
10.1101/2021.08.12.21261806 — Posted: 2021-08-13
Association of Naive B Cells with Humoral Response to SARS-CoV-2 Vaccination
Schulz, E., Hodl, I., Forstner, P., Hatzl, S., Sareban, N., Moritz, M., Fessler, J., Dreo, B., Uhl, B., Url, C., Grisold, A., Khalil, M., Kleinhappl, B., Enzinger, C., Stradner, M. H., Greinix, H., Schlenke, P., Steinmetz, I.
10.1101/2021.08.11.21261898 — Posted: 2021-08-13
The influence of repeated mild lockdown on mental and physical health during the COVID-19 pandemic: a large-scale longitudinal study in Japan
Yamamoto, T., Uchiumi, C., Suzuki, N., Sugaya, N., Murillo-Rodriguez, E., Machado, S., Imperatori, C., Budde, H.
10.1101/2021.08.10.21261878 — Posted: 2021-08-13
Pandemic excess mortality in Spain, Sweden, and Switzerland during the COVID-19 pandemic in 2020 was at its highest since 1918
Staub, K., Panczak, R., Matthes, K. L., Floris, J., Berlin, C., Junker, C., Weitkunat, R., Mamelund, S.-E., Egger, M., Zwahlen, M., Riou, J.
10.1101/2021.08.12.21261825 — Posted: 2021-08-13 Discussion: Onsite
Changing Dynamics of COVID-19 in the U.S. with the Emergence of the Delta Variant: Projections of the COVID-19 Simulator
Chhatwal, J., Xiao, Y., Mueller, P. C. P., Ayer, T., Adee, M. G., Dalgic, O., Ladd, M. A., Linas, B.
10.1101/2021.08.11.21261845 — Posted: 2021-08-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).